Long-Term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures.

Klein, Pavel; Aboumatar, Sami; Brandt, Christian; Dong, Fang; Krauss, Gregory L; Mizne, Sarah; Sanchez-Alvarez, Juan Carlos; Steinhoff, Bernhard J; Villanueva, Vicente

Klein, Pavel; Aboumatar, Sami; Brandt, Christian; Dong, Fang; Krauss, Gregory L; Mizne, Sarah; Sanchez-Alvarez, Juan Carlos; Steinhoff, Bernhard J; Villanueva, Vicente.

Afiliación

Klein P; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA kleinp@epilepsydc.com.
Aboumatar S; Austin Epilepsy Care Center, Austin, TX, USA.
Brandt C; Bethel Epilepsy Centre, Mara Hospital, Bielefeld, Germany.
Dong F; SK Life Science, Inc., Paramus, NJ, USA.
Krauss GL; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mizne S; MedVal Scientific Information Services, Princeton, NJ, USA.
Sanchez-Alvarez JC; Unidad de Epilepsia, Hospital Vithas la Salud, Granada, Spain.
Steinhoff BJ; Kork Epilepsy Center, Kehl-Kork, Germany.
Villanueva V; Department of Neurology and Neurophysiology, University of Freiburg, Freiburg, Germany.

Neurology ; 2022 Jun 15.

Article en En | MEDLINE | ID: mdl-35705501

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Neurology Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google